These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 11406921

  • 1. Meeting the challenges of vascular dementia. Introduction.
    Small G.
    Int J Clin Pract Suppl; 2001 May; (120):1-4. PubMed ID: 11406921
    [Abstract] [Full Text] [Related]

  • 2. Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease.
    Gauthier S, Ferris S.
    Int J Clin Pract Suppl; 2001 May; (120):29-39. PubMed ID: 11406924
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease.
    Bennett D.
    Int J Clin Pract Suppl; 2001 May; (120):41-8. PubMed ID: 11406925
    [Abstract] [Full Text] [Related]

  • 7. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.
    Erkinjuntti T.
    Int J Clin Pract Suppl; 2001 May; (120):14-23. PubMed ID: 11406922
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM, Lyons D, Shin IS, Yoon JS.
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
    Chen X, Zhang ZX, Huang JB, Wen HB.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
    [Abstract] [Full Text] [Related]

  • 11. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R.
    MMW Fortschr Med; 2002 May 06; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [Abstract] [Full Text] [Related]

  • 12. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6).
    Erkinjuntti T, Gauthier S, Bullock R, Kurz A, Hammond G, Schwalen S, Zhu Y, Brashear R.
    J Psychopharmacol; 2008 Sep 06; 22(7):761-8. PubMed ID: 18308781
    [Abstract] [Full Text] [Related]

  • 13. Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
    Corey-Bloom J.
    Int J Clin Pract; 2003 Apr 06; 57(3):219-23. PubMed ID: 12723727
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Galantamine: use in Alzheimer's disease and related disorders.
    Bullock R.
    Expert Rev Neurother; 2004 Mar 06; 4(2):153-63. PubMed ID: 15853556
    [Abstract] [Full Text] [Related]

  • 17. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S.
    Am J Geriatr Pharmacother; 2006 Mar 06; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [Abstract] [Full Text] [Related]

  • 18. Vascular dementia and Alzheimer's disease: the unsolved problem of clinical and neuropsychological differential diagnosis.
    Misciagna S, Masullo C, Giordano A, Silveri MC.
    Int J Neurosci; 2005 Dec 06; 115(12):1657-67. PubMed ID: 16287632
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.